Stay updated on Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial
Sign up to get notified when there's something new on the Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial page.

Latest updates to the Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial page
- Check3 days agoChange DetectedThe history shows updates to the study record across versions, including changes to Study Status, Recruitment Status, and sections such as Outcome Measures and Eligibility. It also highlights QC/Quality Control Review status across versions.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded Revision: v3.4.2. Removed the prior funding notice (lapse in government funding) and the older Revision: v3.4.1 from the page.SummaryDifference0.7%

- Check31 days agoChange DetectedAdded a government funding status notice to the page. Updated the version history to v3.4.1, replacing the previous v3.4.0 entry.SummaryDifference0.7%

- Check39 days agoChange DetectedUI updates to the Record History page include a glossary toggle and color-coded highlights for changes (green for additions, red for deletions) with a new revision label (v3.4.0). Older No FEAR Act data and the revision label (v3.3.4) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check53 days agoChange DetectedRevision history now shows a new revision label v3.3.4 and removes the previous revision v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded Revision: v3.3.3 to the page and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial page.